Articles from OpenEvidence

OpenEvidence, the most widely used medical AI and clinical decision-making tool among U.S. physicians, and Penn Medicine today announced a global partnership to bring AI-powered clinical decision support to Penn Medicine's more than 10,000 clinicians across its seven-hospital U.S. health system.

OpenEvidence and the Medical Identification Number for Canada Corporation (MINC#NIMC) today announced a partnership to streamline physician verification for Canada and support continued free access for verified Canadian clinicians.

Today, OpenEvidence is releasing a new family of medical AI models, named for founders of modern medicine: Osler, our fastest model (~5s to answer), built for the pace of the patient encounter; Sackett, a deeper search model (~30s to answer) for questions that turn on the weight of the evidence; and Snow, our deepest production model (~5m to answer), which runs a full investigation of the world’s medical literature before it writes a word.

The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence today announced a partnership that will focus on co-developing AI-powered educational resources on sports medicine for both patients and clinicians. This exclusive collaboration brings the expertise of AMSSM’s sports medicine physicians to OpenEvidence, the leading AI-powered clinical decision support platform, and will build on the AMSSM’s robust foundation of educational materials.

OpenEvidence, the most widely used AI-powered medical search and clinical decision-support platform, and OneOncology, a physician-led national platform empowering independent medical specialty practices, today announced a partnership to embed OpenEvidence into certain clinical applications used across OneOncology’s platform to enable physicians to use OpenEvidence for clinical evidence retrieval, reference and research. The integration is designed to make it easier for physicians at OneOncology partner practices to access OpenEvidence directly within their clinical workflows.

Springer Nature and OpenEvidence today announced a subscription agreement that brings peer-reviewed content from Springer Nature into OpenEvidence, where physicians can retrieve and cite it during patient care. This agreement took effect August 4 and forms part of Springer Nature’s community led ARC3 framework.

OpenEvidence, the leading AI-powered medical search and decision support platform, has launched a new education platform offering accredited, interprofessional continuing education (CE) and Maintenance of Certification (MOC) credits for NPI-verified physicians, nurse practitioners, and physician associates. Physicians can additionally earn Maintenance of Certification (MOC) credit through select certifying boards. As AI-powered clinical tools become increasingly common, it is essential that accredited CE keeps pace with the evolving reality of practice. The OpenEvidence Education Platform is powered by the same underlying models that support OpenEvidence, adapted to create personalized, accredited learning experiences for clinicians.

The Los Angeles County Department of Public Health (DPH) and OpenEvidence, an AI-powered clinical decision support platform, today announced a collaboration to help physicians quickly find official LA County Public Health resources when searching for clinical information. Under this new partnership, when physicians in LA County search the platform for selected public health topics, OpenEvidence will display related LA-specific messages from Public Health. The messages connect clinicians to local public health resources and health alerts related to reportable diseases, outbreaks, and other time sensitive public health issues.

Boston Children's Hospital, one of the nation's top pediatric hospitals, and OpenEvidence, the leading AI-powered clinical decision support platform, today announced a multi-year collaboration to examine how clinicians' real-world use of AI tools at the point of care relates to practice patterns and delivery of care.

The American Academy of Pediatrics, the largest professional association of pediatricians, announces a new collaboration with OpenEvidence — the leading AI-powered clinical decision support platform — that will provide clinicians with guidance from the latest AAP policies, recommendations, and pediatric research.

OpenEvidence, a medical AI and clinical decision support tool for U.S. clinicians, today announced a collaboration with NewYork-Presbyterian and its affiliated medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, to deploy OpenEvidence across all hospitals and care sites throughout the Greater New York region. This enterprise-scale collaboration will place trusted, evidence-based clinical AI in the hands of providers serving millions of patients across New York City's five boroughs and Westchester.

OpenEvidence and the Anticoagulation Forum (AC Forum) today announced a strategic partnership to provide antithrombotic guidance and tools that support decision-making in clinical practice. By combining the AC Forum’s leadership in education and multidisciplinary clinical guidance with OpenEvidence’s advanced artificial intelligence platform, clinicians will gain access to timely and practical evidence in antithrombotic therapy.

OpenEvidence and the Journal of Medical Insight (JOMI, jomi.com) today announced OpenEvidence's first video evidence collaboration, bringing peer-reviewed surgical video onto the platform. With JOMI's library now available, clinicians who ask a question at the point of care can receive not only an evidence-based answer in text, but a demonstrated surgical technique performed by an established surgeon, shown exactly when and where it's needed.

The Society for Neuro-Oncology (SNO), the world's largest multidisciplinary organization dedicated to advancing research, education, and clinical care for patients with brain and spinal cord tumors, and OpenEvidence, the leading AI-powered clinical decision support platform, today announced a landmark partnership, designating OpenEvidence as SNO's official generative AI partner. As part of the collaboration, SNO will embed OpenEvidence across its member-facing digital properties, expanding access to evidence-based clinical decision support for the physicians who diagnose and treat brain and spinal cord tumors.

The American Academy of Ophthalmology, the world’s largest association of eye physicians and surgeons, and OpenEvidence, the most widely used medical AI platform among U.S. physicians, today announced a strategic partnership to integrate the Academy’s Preferred Practice Patterns® and Ophthalmic Technology Assessments directly into the OpenEvidence platform. The partnership makes the Academy’s authoritative ophthalmology guidance available alongside the broader peer-reviewed medical literature in a cited, searchable workflow — at no cost to ophthalmologists.

Today, OpenEvidence, the most widely used medical knowledge platform, announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model.

OpenEvidence, the most widely used medical AI platform among U.S. physicians, today launched Voice Mode, the first native speech-to-speech medical AI interface. With Voice Mode, OpenEvidence becomes the first multimodal medical AI offering a hands-free way for clinicians to ask questions aloud, and hear cited answers read back, on the same peer-reviewed evidence base. The feature is live in the OpenEvidence web and mobile apps and is free for all users.

Today, the Society of Surgical Oncology (SSO), a global professional society for cancer surgeons, and OpenEvidence, the most widely used medical knowledge platform, announced a strategic partnership to strengthen access to the most trusted surgical oncology evidence at the point of care while building a foundation for innovative collaborations to support surgeons and all physicians taking care of patients with cancer.

The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA’s evidence-based asthma strategy reports, clinical recommendations, and educational resources available directly through OpenEvidence. Under the agreement, OpenEvidence becomes a key content partner for GINA, driving the digital dissemination of asthma standards to clinicians across OpenEvidence’s rapidly expanding international footprint.

Today, OpenEvidence and American College of Obstetricians & Gynecologists (ACOG) announced a strategic collaboration to expand access to ACOG’s evidence-based clinical guidance and develop insights to help inform the future of ob-gyn care and women’s health.

The American Urological Association (AUA) and OpenEvidence, a leading AI-powered clinical decision support platform, today announced a new multi-year collaboration that will make AUA Clinical Practice Guidelines and Clinical Consensus Statements accessible within the OpenEvidence platform.

OpenEvidence now integrates National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) directly in answers, grounding responses in the pinnacle reference resource defining and advancing care in oncology. OpenEvidence’s collaboration with NCCN marks the beginning of a series of focused oncology-related updates to the platform—in conjunction with leading experts in oncology—to help clinicians give the best possible care to patients in one of the most challenging areas of healthcare.

OpenEvidence, the most widely used medical AI and clinical decision-support platform among U.S. physicians, today announced the release of Dotflows, enabling clinicians to tailor the platform to the way they uniquely practice medicine.

OpenEvidence, the leader in AI-powered medical search and clinical decision support, and Tandem, the leader closing the gap between breakthrough medications and patient access, today announced a strategic partnership to dramatically accelerate how patients access lifesaving medications.

The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) and OpenEvidence, a leading AI-powered medical search and decision support platform, have partnered to help keep clinical practice guidelines aligned with the latest evidence while scaling up coverage. This first-of-its-kind approach leverages OpenEvidence’s technology and up-to-date to the day evidence base to augment expert clinician insight and real-world expertise in creating and updating practice guidelines.

The National Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families.

Sutter Health and OpenEvidence are teaming up to deliver the latest medical data and information to doctors working within electronic health records. This collaboration will help Sutter clinicians quickly find and use up-to-date clinical information – helping the system meet its high standards for quality, safety and patient-centered care.

OpenEvidence, the most widely-used AI platform by doctors in America, announced today that it closed a Series D round of funding, valuing the company at $12 billion. This makes OpenEvidence the most valuable Healthcare AI company in the world.